-
- 1800 2010
- EN
News
Array
(
[0] => stdClass Object
(
[id] => 1429
[id_crawler] =>
[category_product] => NULL
[thumbnail] => huyen.8.2021/pshn1.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2026-04-29
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2026-04-29 15:31:35
[updated_time] => 2026-05-04 10:22:42
[files] =>
[salary] =>
[time] =>
[created_by] => 1
[is_table_content] => 0
[language_code] => en
[slug] => Scientific-seminar-Eurofins-GENTIS-updates-PGT-M-testing-at-Hanoi-obstetrics-and-gynecology-hospital
[title] => Scientific seminar: Eurofins GENTIS updates PGT-M testing at Hanoi obstetrics and gynecology hospital
[description] => On April 28, 2026, at Hanoi obstetrics and gynecology hospital, Eurofins GENTIS genetic analysis services joint stock company held a scientific seminar and professional exchange with doctors, specialists, and midwives from the hospital’s department of assisted reproduction & andrology. The session focused on updating in-depth knowledge about PGT-M testing—one of the key tests in assisted reproduction, which helps screen embryos for single-gene genetic disorders before embryo transfer.
[content] => 
Enhancing professional updates in assisted reproduction
Attending the seminar was Dr. Nguyen Thi My Dung, specialist level II – head of the department of assisted reproduction & andrology, along with numerous doctors, experts, and midwives from Hanoi obstetrics and gynecology hospital.
Representing Eurofins GENTIS, MSc. Nguyen Van Huynh – head of R&D, delivered a presentation titled: “Overview of PGT-M testing at Eurofins GENTIS.” The presentation attracted strong interest and active discussions from attending experts, contributing to improved professional knowledge and practical application in treatment.
PGT-M – a solution for genetic disease screening at the embryo stage
PGT (preimplantation genetic testing) is a genetic analysis performed before embryo transfer, helping select the best embryos genetically, free from chromosomal abnormalities or disease-causing genes.
PGT-M is specifically applied for couples at risk of passing single-gene disorders to their offspring, enabling detection and exclusion of affected embryos.
Common groups of single-gene genetic disorders:
Autosomal recessive disorders:
- Thalassemia (HBA, HBB)
- Spinal muscular atrophy (SMN1)
- Congenital deafness (GJB2)
- Citrin deficiency (SLC25A13)
Autosomal dominant disorders:
- Achondroplasia (FGFR3)
- Marfan syndrome (FBN1)
- Familial hypercholesterolemia (LDLR)
- Polycystic kidney disease (PKD1, PKD2)
X-linked disorders:
- Duchenne muscular dystrophy (DMD)
- Hemophilia A, B (F8, F9)
- G6PD deficiency
- Fabry disease (GLA)
Key highlights of PGT-M testing at Eurofins GENTIS
PGT-M testing at Eurofins GENTIS is developed and optimized according to international standards, offering several outstanding advantages:
- Application of bioinformatics software to select genetic markers suitable for the Vietnamese population, optimizing analysis time and cost
- Procedures compliant with ESHRE 2020 recommendations, ensuring standardization and high reliability
- CAP-accredited laboratory for PGT and NIPT services with strict quality control
- Capability to analyze more than 100 genes/diseases, meeting diverse clinical needs
- Combination of direct mutation detection and linkage analysis methods to enhance accuracy
Optimized turnaround time:
- Thalassemia: approximately 12 days
- Other rare diseases: from 20–60 days
Promoting professional collaboration – enhancing treatment quality
Through this scientific seminar, Eurofins GENTIS reaffirmed its commitment to partnering with healthcare institutions in updating advanced testing technologies, contributing to improved diagnostic and treatment outcomes in assisted reproduction.
The close collaboration between Eurofins GENTIS and Hanoi obstetrics and gynecology hospital not only brings professional value but also expands access to modern genetic solutions for patients, aiming toward the goal of giving birth to healthy babies from the very beginning.
In the context of the rapid development of precision medicine, the role of newborn screening testing has become increasingly important. This is the first step in early detection of inborn errors of metabolism (IEM), enabling timely intervention and improving children’s quality of life. However, alongside advances in testing technology come growing challenges in accurately, consistently, and systematically analyzing and interpreting data.
LC-MS/MS – a powerful tool in screening inborn errors of metabolism
According to Dr. Nguyen Huy Dong, LC-MS/MS (liquid chromatography – tandem mass spectrometry) is currently considered the “gold standard” in newborn screening for metabolic disorders. A key advantage of this method is its ability to simultaneously analyze dozens of biochemical markers from a single sample, expanding disease detection capacity and improving screening efficiency.
Unlike traditional methods that focus on only a few biomarkers, LC-MS/MS enables comprehensive evaluation of metabolite groups such as amino acids and acylcarnitines. This is particularly important because IEM disorders often present complex biochemical patterns involving multiple metabolic pathways in the body.
However, the diversity and complexity of the data also require more advanced analysis and interpretation. Relying on a single indicator may lead to inaccuracies, missed diagnoses, or increased false-positive rates. Therefore, modern approaches require evaluating data in an integrated manner, based on characteristic disease models for each disorder.
Challenges in interpreting IEM test results
Currently, more than 100 inborn errors of metabolism have been identified, each with its own distinct “biochemical signature.” This means laboratory specialists must possess extensive knowledge and practical experience to accurately recognize abnormal patterns.
In practice, result interpretation still largely depends on individual expertise, which may lead to inconsistencies between institutions or even among individuals within the same organization. In addition, factors such as sample quality, gestational age, sampling time, and the child’s nutritional status can affect test results, further increasing the complexity of evaluation.
Therefore, the need for an automated interpretation support tool that can standardize and integrate data is becoming increasingly essential. This is also the reason Eurofins GENTIS implemented training on Clinmind software—a technological solution that supports systematic and scientific analysis and interpretation of newborn screening results.
Clinmind – a solution to improve accuracy and consistency
Clinmind software is designed to support experts in analyzing LC-MS/MS data through a multidimensional approach. Instead of focusing on individual indicators, the system allows simultaneous evaluation of multiple parameters, thereby building analysis models suitable for each disease group.
Within the training program, Eurofins GENTIS staff were guided in detail on approaches in newborn screening, including:
Single analyte analysis
This is the basic method in which the concentration of a primary metabolite is measured and compared with a normal threshold (cut-off). It is simple and easy to apply but has limitations in sensitivity and specificity. In addition, cut-off thresholds may need adjustment depending on factors such as sample quality, gestational age, sampling time, and the child’s nutritional status.
Dual analyte analysis
To overcome the limitations of single analyte analysis, combining two biochemical indicators is used to improve sensitivity and specificity. Evaluating the correlation between two metabolites enhances the ability to distinguish between normal and abnormal cases, thereby improving screening effectiveness.
Multiple analyte analysis
This is the most advanced method, allowing simultaneous measurement of multiple amino acids and acylcarnitines in a single sample. By analyzing overall indicators, this approach significantly reduces false-positive rates and increases result reliability. It also enables the detection of multiple conditions in a single test.
Through the application of Clinmind, data from these three approaches can be integrated and analyzed systematically, leading to more accurate and consistent conclusions.
Enhancing team capacity – a foundation for sustainable development
The training program not only helps Eurofins GENTIS staff master the use of the software but also strengthens their expertise in inborn metabolic disorders and modern approaches in newborn screening.
This is part of the company’s long-term strategy to build a highly capable team that meets the increasingly stringent requirements of genetic testing and genomic medicine. Continuous updates in knowledge and technology help ensure service quality and enhance the company’s reputation within the medical community.
Commitment to innovation and technology application
With a sustainable development orientation, Eurofins GENTIS continuously invests in research, development, and the application of advanced technological solutions. The implementation of Clinmind training demonstrates the company’s commitment to improving testing quality and optimizing result interpretation processes.
In the future, Eurofins GENTIS will continue to expand collaboration with domestic and international partners to deliver more comprehensive solutions in genetic testing. At the same time, the company aims to build a precision medicine ecosystem where genetic data is effectively utilized for diagnosis, treatment, and disease prevention.
The Clinmind training program is not only an internal capacity-building activity but also an important step toward standardizing and modernizing newborn screening processes at Eurofins GENTIS. By combining advanced technology with deep expertise, the company is gradually strengthening its position in the field of genetic testing and genomic medicine in Vietnam.
In the context of increasingly personalized medicine, such efforts will play a vital role in improving community healthcare quality, especially in protecting the health of future generations from the earliest days of life.
[content_more] => [meta_title] => Eurofins GENTIS promotes-training-collaboration-on-Clinmind-software-for-newborn-screening-result-in [meta_description] => On April 24, 2026, Eurofins GENTIS organized an internal training program on Clinmind software for interpreting newborn screening test results, led directly by Dr. Nguyen Huy Dong – R&D specialist of the company. This activity is part of the strategy to e [meta_keyword] => Gentis [thumbnail_alt] => [post_id] => 1428 [category_id] => 4 ) [2] => stdClass Object ( [id] => 1427 [id_crawler] => [category_product] => NULL [thumbnail] => huyen.8.2021/green_sm_600-400.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-04-24 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-04-24 16:09:15 [updated_time] => 2026-05-04 10:30:35 [files] => [salary] => [time] => [created_by] => 1 [is_table_content] => 0 [language_code] => en [slug] => Accurate-testing-effortless-travel-with-Eurofins-GENTIS-and-Green-SM [title] => Accurate testing – effortless travel with Eurofins GENTIS and Green SM [description] => To make it more convenient for customers traveling to testing centers and hospitals, Eurofins GENTIS has partnered with Green SM to provide a smarter solution—making your journey for testing easier and more cost-effective than ever. [content] =>
Easy travel – peace of mind for testing
Now, with just a few simple steps on the Green SM app, you can quickly reach Eurofins GENTIS testing centers as well as partner clinics and hospitals. No more worries about directions, traffic congestion, or unexpected costs—everything is optimized so you can focus on taking care of your health and your family.
Exclusive offers for customers
When choosing to travel with Green SM to Eurofins GENTIS, you can enjoy attractive benefits:
- Discounts of up to 40,000 VND per trip
- Applicable for rides with pick-up or drop-off points at Eurofins GENTIS and its partner network
- Flexible service options: Green SM Car / Green SM Premium / Green SM Limo / Green SM Bike / Green SM Bike Plus
Experience international-standard testing services
Beyond convenient transportation, Eurofins GENTIS is a pioneer in genetic testing in Vietnam, equipped with modern laboratories that meet strict international standards. Customers can feel confident in the accuracy, confidentiality, and quality of services.
Book now – enjoy a seamless journey
Taking care of your health has never been easier. Start your journey today with a convenient and cost-saving ride:
Book Green SM here: https://www.greensm.com/vn-vi
Eurofins GENTIS is always by your side on your journey to proactively protect your health—from high-quality testing to the best possible service experience.
[content_more] => [meta_title] => Accurate testing – effortless travel with Eurofins GENTIS and Green SM [meta_description] => To make it more convenient for customers traveling to testing centers and hospitals, Eurofins GENTIS has partnered with Green SM to provide a smarter solution—making your journey for testing easier and more cost-effective than ever. [meta_keyword] => Green Sm [thumbnail_alt] => [post_id] => 1427 [category_id] => 4 ) [3] => stdClass Object ( [id] => 1426 [id_crawler] => [category_product] => NULL [thumbnail] => huyen.8.2021/wweb.png [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-04-20 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-04-21 08:55:25 [updated_time] => 2026-04-21 10:18:20 [files] => [salary] => [time] => [created_by] => 1 [is_table_content] => 0 [language_code] => en [slug] => Announcement-Update-on-non-invasive-prenatal-paternity-DNA-testing-service [title] => Announcement: Update on non-invasive prenatal paternity DNA testing service [description] => In our continuous effort to enhance service quality and deliver the best customer experience, Eurofins GENTIS is pleased to announce updates to our non-invasive prenatal paternity DNA testing service, featuring significant improvements in turnaround time and efficiency. [content] =>1. Key Enhancements
The prenatal paternity DNA testing service at Eurofins GENTIS has been upgraded with the following advantages:
- Earlier testing: Available from as early as the 7th week of pregnancy, enabling customers to make timely decisions.
- Faster results: Flexible turnaround options from 3–10 days to meet diverse needs.
- Absolute safety: A non-invasive method using only the mother’s blood sample, ensuring no risk to the fetus.
2. Advantages of the Testing Method
Non-invasive prenatal paternity DNA testing is a modern solution highly regarded for:
- Requiring only 7–10 ml of the mother’s venous blood
- Early testing capability (from the 7th week of pregnancy)
- High accuracy of up to 99.9%
- Strict confidentiality of customer information
3. Flexible Service Packages
Eurofins GENTIS offers various options to suit customer needs:
- Standard package: Results within 7–10 days
- 7-day express package: Optimized turnaround time at a reasonable cost
- Super express package (3–5 days): Ideal for urgent result requirements
4. Sample Requirements and Conditions
Test samples include:
- Mother: Venous blood
- Alleged father: Blood, buccal swab, nails, hair with roots, or other special samples
Requirements: Ultrasound results confirming gestational age
5. Eurofins GENTIS Quality Commitment
With internationally accredited laboratory systems such as CAP, ISO 9001, and ISO 15189, Eurofins GENTIS is committed to delivering DNA testing services that are:
- Reliable
- Accurate
- Fast
We not only provide test results but also support our customers with in-depth consultation services delivered with dedication and strict confidentiality.
[content_more] => [meta_title] => Announcement: Update on non-invasive prenatal paternity DNA testing service [meta_description] => In our continuous effort to enhance service quality and deliver the best customer experience, Eurofins GENTIS is pleased to announce updates to our non-invasive prenatal paternity DNA testing service, featuring significant improvements in turnaround time [meta_keyword] => ADN [thumbnail_alt] => [post_id] => 1426 [category_id] => 4 ) [4] => stdClass Object ( [id] => 1425 [id_crawler] => [category_product] => NULL [thumbnail] => fe1133a3ddce5c9005df.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-04-16 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-04-16 09:33:00 [updated_time] => 2026-04-17 15:22:09 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Genetic-testing-ecosystem-in-reproductive-support-at-Eurofins-GENTIS [title] => Genetic testing ecosystem in reproductive support at Eurofins GENTIS [description] => The journey of finding and welcoming a child is one of the most sacred milestones for every family. However, alongside happiness comes many concerns, especially those related to reproductive health and genetic factors that may affect fertility and fetal development. In this context, proactive testing, screening, and early detection of potential risks play an essential role. [content] =>Understanding this need, Eurofins GENTIS has developed a comprehensive, scientific, and specialized genetic testing ecosystem for reproductive support. This system is designed to accompany couples at every stage – from preconception, through assisted reproduction, to pregnancy monitoring – helping optimize the chances of having a healthy baby.
Testing for both partners – the foundation for a strong start
Before beginning the journey to parenthood, a comprehensive assessment of reproductive health and genetic risks for both partners is essential. This is a critical first step to detect early abnormalities that may affect fertility or be passed on to the next generation.
Testing for men focuses on evaluating sperm quality, genetic structure, and fertility-related factors. Key tests include:
- AZF: detects Y chromosome microdeletions – a common cause of male infertility
- Sperm DNA fragmentation: evaluates DNA damage in sperm
- Ultragen: screens for genetic disorders
- CFTR gene: identifies risks related to cystic fibrosis
- Karyotyping: detects chromosomal abnormalities in number and structure
- Thalassemia screening
- Carrier screening panel of 28 recessive genes
Testing for women not only evaluates fertility but also identifies factors that may affect pregnancy:
- AMH: assesses ovarian reserve
- HPV: screens for viruses causing
- Cervical cancer
- Karyotyping
- Thalassemia screening
- STDs: screening for sexually transmitted diseases
- FSHR gene: related to ovarian stimulation response
- NK test: evaluates immune cell activity
- Thrombophilia: assesses inherited clotting disorders
- Ultragen
- Carrier screening panel of 28 recessive genes
Completing these tests provides doctors with a comprehensive understanding, enabling them to design the most appropriate and personalized treatment and reproductive support plan for each couple.
Embryo testing and implantation conditions – optimizing success rates
In modern assisted reproductive techniques such as in vitro fertilization (IVF), selecting healthy embryos and ensuring optimal uterine conditions are key factors determining success.
Embryo testing at Eurofins GENTIS analyzes the genetic material of embryos before transfer, helping select those with the best developmental potential:
- PGT-A/SR: screens for chromosomal number and structural abnormalities
- PGT-M: detects single-gene disorders
- PGT-One, PGT-MAX 1, PGT-NEXT,
- PGT-Upgrade, PGT-FAST: optimized testing packages based on different needs
- ASEM test (non-invasive PGT): a non-invasive method that minimizes impact on embryos
At the same time, testing for implantation conditions plays an important role in evaluating uterine receptivity:
- Genratest: analyzes gene expression related to embryo implantation
- PMTest: evaluates the implantation window to determine the optimal embryo transfer timing
The combination of embryo testing and uterine condition assessment can significantly improve IVF success rates while reducing the risk of miscarriage or implantation failure.
Maternal and fetal health testing – comprehensive pregnancy protection
After successful conception, monitoring maternal health and fetal development is an essential next step. Tests during this stage help detect early complications and genetic abnormalities in the fetus.
Key tests include:
- Preeclampsia screening: identifies risks of serious pregnancy complications
- Antiphospholipid testing: detects conditions increasing the risk of miscarriage and thrombosis
- NIPT (GenBasic/GenEva): non-invasive prenatal testing to detect common chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome
- Newborn screening
- Pediatric testing
These tests not only protect maternal health but also ensure close monitoring of fetal development, enabling timely intervention when necessary.
Comprehensive support – enhancing the health of future generations
With a diverse and specialized testing ecosystem built for each stage, Eurofins GENTIS provides a comprehensive solution for reproductive support. Beyond testing services, the company also accompanies families through consultation, guidance, and personalized reproductive health planning.
From preconception preparation and IVF support to pregnancy monitoring, each test serves as an important “piece of the puzzle,” contributing to a safer and more complete journey for both mother and baby.
Proactive testing is the best way to protect your child’s future from the very beginning. By understanding health status and genetic risks, couples can make informed decisions with confidence, aiming for a healthy pregnancy and a higher-quality future generation.
For detailed consultation on the appropriate testing pathway, please contact hotline: 1800 2010
[content_more] => [meta_title] => Genetic testing ecosystem in reproductive support at Eurofins GENTIS [meta_description] => The journey of finding and welcoming a child is one of the most sacred milestones for every family. However, alongside happiness comes many concerns, especially those related to reproductive health and genetic factors that may affect fertility and fetal d [meta_keyword] => Supported ,Reproductive support tests [thumbnail_alt] => [post_id] => 1425 [category_id] => 4 ) [5] => stdClass Object ( [id] => 1424 [id_crawler] => [category_product] => NULL [thumbnail] => bld/anh-bao.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-04-01 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-04-15 10:08:44 [updated_time] => 2026-04-16 13:43:08 [files] => [salary] => [time] => [created_by] => 1 [is_table_content] => 0 [language_code] => en [slug] => Eurofins-GENTIS-announces-appointment-of-chief-executive-officer [title] => Eurofins GENTIS announces appointment of chief executive officer [description] => Eurofins Genetic Testing Services Joint Stock Company (Eurofins GENTIS) has officially announced the appointment of Dr Nguyen Quang Vinh as chief executive officer, effective from March 23, 2026. [content] =>With more than 15 years of dedication to Eurofins GENTIS, Dr Nguyen Quang Vinh is not only one of the founding members but also a key figure in building the company’s scientific and operational foundation. Throughout its development journey, he has held many important roles, particularly in technical expertise and laboratory management – the core elements that define the credibility of a genetic testing organization.
Dr Nguyen Quang Vinh – newly appointed chief executive officer of Eurofins GENTIS
Established in 2010, Eurofins GENTIS has gradually affirmed its position with two large-scale laboratories in Hanoi and Ho Chi Minh City, achieving multiple international certifications such as CAP, ISO 9001:2015, ISO 15189:2022, and ISO/IEC 27001:2022. Each year, the system processes nearly 300,000 genetic test samples, meeting the growing demands of the market.
Beyond laboratory capabilities, the company has developed a network of more than 50 sample collection points nationwide, enabling customers to access services quickly and conveniently. At the same time, Eurofins GENTIS is a trusted partner of many major hospitals and healthcare organizations, as well as leading global biotechnology corporations such as Illumina, Qiagen, and Sigma.
The appointment of Dr Nguyen Quang Vinh to the highest executive position is expected to bring a new momentum to Eurofins GENTIS. With his strong background in genetics and extensive management experience, he is considered well-equipped to lead the company into its next phase of development.
Under the leadership of the new chief executive officer, Eurofins GENTIS is expected to further invest in next-generation sequencing (NGS) technologies, expand its testing portfolio, and enhance service quality to meet international standards. In addition, strengthening partnerships with hospitals, fertility centers, and healthcare organizations both domestically and internationally will be a key focus to expand its service ecosystem and reinforce its pioneering role in genetic testing and diagnostics in Vietnam and the region.
Beyond business growth, Eurofins GENTIS remains committed to its mission of “enhancing the physical and intellectual well-being of Vietnamese people” by bringing advanced genetic solutions closer to the community. This commitment continues to be the guiding principle that helps the company build trust and credibility with its customers over the years.
[content_more] => [meta_title] => Eurofins GENTIS announces appointment of chief executive officer [meta_description] => Eurofins Genetic Testing Services Joint Stock Company (Eurofins GENTIS) has officially announced the appointment of Dr Nguyen Quang Vinh as chief executive officer, effective from March 23, 2026. This marks an important milestone in the company’s long-ter [meta_keyword] => GENTIS,New CEO [thumbnail_alt] => [post_id] => 1424 [category_id] => 4 ) [6] => stdClass Object ( [id] => 1423 [id_crawler] => [category_product] => NULL [thumbnail] => e4e92a4ae82969773038.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-04-15 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-04-15 09:49:46 [updated_time] => 2026-04-16 13:40:51 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Working-announcement-during-Hung-Kings-Commemoration-Day-and-April-30-May-1-holiday [title] => Working announcement during Hung Kings’ Commemoration Day and April 30 – May 1 holiday [description] => Dear valued customers and partners, [content] =>Hung Kings’ Commemoration Day (10th day of the third lunar month) and the April 30 – May 1 holiday are important milestones with special significance for the Vietnamese people. During this solemn and meaningful time, many agencies, organizations, and businesses temporarily suspend operations for the holiday. However, with the aim of ensuring work continuity and delivering the best service experience to customers, Eurofins GENTIS would like to announce its working plan during the holiday as follows:
- maintaining operations throughout the holiday
To promptly meet the needs of our valued customers and partners, Eurofins GENTIS will continue normal operations on Hung Kings’ Commemoration Day (10th day of the third lunar month).
This means that all departments within our system will operate according to the standard working schedule without interruption, including:
- Laboratory department
- Customer service department
- Sample collection and result delivery department
Maintaining operations during the holiday is one of our efforts to ensure work progress is not affected, especially for time-sensitive services that require prompt processing.
Eurofins GENTIS understands that for our customers, every service request is important and requires the highest level of accuracy. Therefore, even during the holiday period, we remain committed to:
- Maintaining stable performance without delays or interruptions
- Ensuring quick response times and timely support for all inquiries and requests
- Upholding service quality and strictly complying with professional standards and quality control processes
We believe that consistency and professionalism at all times – including holidays – are key factors in building long-term trust and relationships with our customers and partners.
- enhancing customer support during the holiday
During the holiday period, demand for consultation and services may increase as customers have more time to arrange personal matters. Understanding this, Eurofins GENTIS has proactively prepared resources to:
- Ensure the consulting team is always ready to support
- Enhance the capacity to receive and process requests
- Reduce customer waiting time
We always place customer experience at the center, and all processes are optimized to provide maximum convenience and satisfaction.
If you need consultation, support, or have any inquiries related to our services, please contact us via: hotline: 1800 2010
Our team is always ready to listen and assist you with dedication, promptness, and efficiency.
On the occasion of Hung Kings’ Commemoration Day, Eurofins GENTIS would like to express our sincere thanks to our valued customers and partners for your trust, support, and companionship over the years.
Your support is a great motivation for us to continuously improve service quality, optimize processes, and pursue sustainable development.
We wish our valued customers and partners a peaceful, joyful, and meaningful holiday with your family and loved ones.
Sincerely,
Eurofins GENTIS
With the desire to accompany families during this special stage, Eurofins GENTIS collaborated with Hanoi Andrology and Infertility Hospital to successfully organize a prenatal class with the theme “PROPER VACCINATION – PROTECTING MOTHERS, STRENGTHENING BABIES”. The program took place in a warm and friendly atmosphere, attracting many expectant mothers and families preparing to welcome their babies.
From the very beginning, the class became an open sharing space where expectant mothers could freely ask questions, express concerns, and receive dedicated advice from experts. In particular, the session led by Dr Do Thi Huyen on the topic “Vaccination in pregnant women – a shield protecting the health of mother and baby” provided practical, scientific, and easy-to-understand information.
One of the most discussed topics was why vaccination is necessary during pregnancy. Through the doctor’s presentation, participants clearly understood that vaccination not only protects mothers from dangerous infectious diseases but also creates an immune “shield” for the fetus from the womb. This is an essential preparation step to reduce the risk of complications during pregnancy and protect the baby in the first months of life, when the immune system is still immature.
In addition, important vaccination milestones during pregnancy were analyzed in detail. Essential vaccines such as tetanus, influenza, and pertussis were clearly explained in terms of appropriate timing, effectiveness, and necessary precautions. This helps expectant mothers proactively build a safe and scientific vaccination plan for themselves.
Beyond providing knowledge, the class also addressed many practical concerns commonly raised by mothers, such as whether vaccination affects the fetus, what to do before and after vaccination, and how to monitor post-vaccination reactions to ensure safety. Clear and practical explanations from the doctor helped ease common worries and provided reassurance throughout pregnancy care.
A special highlight of the program was not only its professional content but also the emotional connection among participants. Expectant mothers had the opportunity to meet, interact, and share personal experiences. This sense of empathy and sharing created a warm and supportive environment where no one felt alone on the journey to motherhood.
For Eurofins GENTIS, participating in community health education programs, especially prenatal classes, is part of its commitment to delivering sustainable value to society. Beyond providing high-quality testing and diagnostic services, the organization aims to spread accurate medical knowledge and enhance public awareness of proactive healthcare.
The collaboration with Hanoi Andrology and Infertility Hospital in this program once again affirms a shared effort to build a comprehensive support system for families. From examination and treatment to education and counseling, all activities aim to help couples experience a safe, healthy, and fulfilling pregnancy journey.
As the class concluded, what remained was not only valuable knowledge but also a visible sense of relief and reassurance on the faces of expectant mothers. Bright smiles and hopeful eyes clearly reflected the value the program brought. Each mother left the session feeling more confident in caring for herself and protecting her baby.
It can be said that the prenatal class “PROPER VACCINATION – PROTECTING MOTHERS, STRENGTHENING BABIES” was not just a knowledge-sharing session but also a source of inspiration and emotional support for families. With the right information and guidance from experts, the pregnancy journey becomes much smoother and more meaningful.
In the future, Eurofins GENTIS aims to continue delivering more practical programs to support families in welcoming new life. Because every healthy newborn is not only a joy for each family but also for the entire community.
[content_more] => [meta_title] => The prenatal class “Proper vaccination – protecting mothers, strengthening babies” concluded with ma [meta_description] => On the journey to welcome a little angel, every mother carries a mix of happiness and concern. Pregnancy is not only a physical transformation but also a journey of learning, preparation, and adaptation to bring the best for the baby from the very beginni [meta_keyword] => GENTIS,prenatal cleass [thumbnail_alt] => [post_id] => 1422 [category_id] => 4 ) )
Scientific seminar: Eurofins GENTIS updates PGT-M testing at Hanoi obstetrics and gynecology hospital
Eurofins GENTIS promotes training collaboration on Clinmind software for newborn screening result interpretation
Accurate testing – effortless travel with Eurofins GENTIS and Green SM
Announcement: Update on non-invasive prenatal paternity DNA testing service
Genetic testing ecosystem in reproductive support at Eurofins GENTIS
Eurofins GENTIS announces appointment of chief executive officer
Working announcement during Hung Kings’ Commemoration Day and April 30 – May 1 holiday
The prenatal class “Proper vaccination – protecting mothers, strengthening babies” concluded with many emotions
Please fill in the information below to receive our supports and consultations!
Please fill in the information below to receive our supports and consultations!
